Fidelity Investments’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.8M | Sell |
2,058,069
-20,590
| -1% | -$448K | ﹤0.01% | 1440 |
|
|
2025
Q1 | $38.4M | Sell |
2,078,659
-22,378
| -1% | -$414K | ﹤0.01% | 1453 |
|
|
2024
Q4 | $56M | Sell |
2,101,037
-18,658
| -0.9% | -$497K | ﹤0.01% | 1340 |
|
|
2024
Q3 | $49.8M | Buy |
2,119,695
+169,514
| +9% | +$3.98M | ﹤0.01% | 1373 |
|
|
2024
Q2 | $36.2M | Buy |
1,950,181
+147
| +0% | +$2.73K | ﹤0.01% | 1435 |
|
|
2024
Q1 | $34.8M | Buy |
+1,950,034
| New | +$34.8M | ﹤0.01% | 1464 |
|